Yasuo Kurata

1.3k total citations
13 papers, 1.1k citations indexed

About

Yasuo Kurata is a scholar working on Infectious Diseases, Animal Science and Zoology and Oncology. According to data from OpenAlex, Yasuo Kurata has authored 13 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 3 papers in Animal Science and Zoology and 3 papers in Oncology. Recurrent topics in Yasuo Kurata's work include SARS-CoV-2 and COVID-19 Research (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Animal Virus Infections Studies (3 papers). Yasuo Kurata is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Animal Virus Infections Studies (3 papers). Yasuo Kurata collaborates with scholars based in Japan. Yasuo Kurata's co-authors include Shun Higuchi, Kenji Otsubo, Mizuho Tanabe, Masakuni Takahashi, Ichiro Ieiri, Kazuko Inoue, Yasunobu Kanamori, Naoki Nagata, Nobuyuki Sera and Katsumi Chijiwa and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Emerging infectious diseases and Clinical Pharmacology & Therapeutics.

In The Last Decade

Yasuo Kurata

11 papers receiving 1.1k citations

Peers

Countries citing papers authored by Yasuo Kurata

Since Specialization

Citations

This map shows the geographic impact of Yasuo Kurata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yasuo Kurata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yasuo Kurata more than expected).

Fields of papers citing papers by Yasuo Kurata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yasuo Kurata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yasuo Kurata. The network helps show where Yasuo Kurata may publish in the future.

Co-authorship network of co-authors of Yasuo Kurata

This figure shows the co-authorship network connecting the top 25 collaborators of Yasuo Kurata. A scholar is included among the top collaborators of Yasuo Kurata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yasuo Kurata. Yasuo Kurata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Reduction of adverse reactions and correlation between post-vaccination fever and specific antibody response across successive SARS-CoV-2 mRNA vaccinations 2024 ·Vaccine X ·Naoki Tani, Hideyuki Ikematsu, (unknown), (unknown), (unknown), Yasuo Kurata, (unknown), Takahiko Horiuchi, Koichi Akashi, Nobuyuki Shimono, Yong Chong	2
2	Impact of Antimicrobial Stewardship in Patients with Acute Respiratory Tract Infection and Acute Diarrhea Treated in an Outpatient Department 2023 ·Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) ·(unknown), Yasuo Kurata, Noboru Inoue, Hisashi Horiuchi, (unknown), (unknown), (unknown), (unknown)	0
3	Correlation of Postvaccination Fever With Specific Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 BNT162b2 Booster and No Significant Influence of Antipyretic Medication 2022 ·Open Forum Infectious Diseases ·Naoki Tani, Hideyuki Ikematsu, (unknown), (unknown), (unknown), (unknown), Yasuo Kurata, (unknown), (unknown), (unknown), (unknown), Hiroyuki Kuwano, Koichi Akashi, Nobuyuki Shimono, Yong Chong	11
4	No significant influence of pre-vaccination antipyretic use on specific antibody response to a BNT162b2 vaccine booster against COVID-19 2022 ·Vaccine X ·Naoki Tani, Hideyuki Ikematsu, (unknown), (unknown), (unknown), Yasuo Kurata, (unknown), (unknown), (unknown), (unknown), Hiroyuki Kuwano, Koichi Akashi, Nobuyuki Shimono, Yong Chong	4
5	Monitoring of Adverse Events Associated with COVID-19 Vaccine (Tozinameran) -Influence of Sex, Age, and Number of Doses on the Frequencies of Adverse Reactions- 2022 ·Kansenshogaku zasshi ·Yasuo Kurata, (unknown), (unknown), (unknown), Naoki Tani, (unknown), (unknown), (unknown), (unknown), Hiroyuki Kuwano	0
6	Effect of liver cirrhosis on theophylline trough concentrations: A comparative analysis of organ impairment using Child–Pugh and MELD scores 2022 ·British Journal of Clinical Pharmacology ·Yasuo Kurata, (unknown), Takeshi Hirota, (unknown), Ichiro Ieiri	3
7	Relation of fever intensity and antipyretic use with specific antibody response after two doses of the BNT162b2 mRNA vaccine 2022 ·Vaccine ·Naoki Tani, Yong Chong, Yasuo Kurata, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Nobuyuki Shimono, Hideyuki Ikematsu, Hiroyuki Kuwano	26
8	Reduced theophylline clearance due to hepatic congestion secondary to right heart failure - A population pharmacokinetic study 2021 ·Drug Metabolism and Pharmacokinetics ·Yasuo Kurata, (unknown), Takeshi Hirota, (unknown), Ichiro Ieiri	2
9	Effect of Antimicrobial Stewardship on Reduced Oral Antibiotic Use and Bacterial Resistance at an Outpatient Department in a Medium-Sized Hospital -Achievement of the Target Values of the National Action Plan on Antimicrobial Resistance in Japan- 2021 ·Japanese Journal of Infection Prevention and Control ·Yasuo Kurata, (unknown), (unknown)	1
10	Differences in Theophylline Clearance Between Patients With Chronic Hepatitis and Those With Liver Cirrhosis 2020 ·Therapeutic Drug Monitoring ·Yasuo Kurata, (unknown), (unknown), Takeshi Hirota, (unknown), Ichiro Ieiri	4
11	Hepatitis E Virus Transmission from Wild Boar Meat 2005 ·Emerging infectious diseases ·Tian‐Cheng Li, Katsumi Chijiwa, Nobuyuki Sera, Tetsuya Ishibashi, Yoshiki Etoh, Yuji Shinohara, Yasuo Kurata, Miki Ishida, Shigeru Sakamoto, Naokazu Takeda, Tatsuo Miyamura	376
12	Role of human MDR1 gene polymorphism in bioavailability and interaction of digoxin, a substrate of P‐glycoprotein 2002 ·Clinical Pharmacology & Therapeutics ·Yasuo Kurata, Ichiro Ieiri, Miyuki Kimura, Toshihiro Morita, Shin Irie, Akinori Urae, Shigehiro Ohdo, Hisakazu Ohtani, Yasufumi Sawada, Shun Higuchi, Kenji Otsubo	221
13	Expression of P-glycoprotein in Human Placenta: Relation to Genetic Polymorphism of the Multidrug Resistance (MDR)-1 Gene 2001 ·Journal of Pharmacology and Experimental Therapeutics ·Mizuho Tanabe, Ichiro Ieiri, Naoki Nagata, Kazuko Inoue, (unknown), Yasunobu Kanamori, Masakuni Takahashi, Yasuo Kurata, (unknown), Shun Higuchi, (unknown), Kenji Otsubo	459

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact